Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients.

Objective: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have well-documented effects in reducing hospitalization or cardiovascular mortality, while the association of SGLT2 inhibitor dapagliflozin (DAPA) and the risk of acute kidney injury (AKI) in acute myocardial infarction (AMI) patients has...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Clinical Pharmacology Vol. 80; no. 4; pp. 613 - 621
Autores principales:	Cai, Dabei, Chen, Qianwen, Mao, Lipeng, Xiao, Tingting, Wang, Yu, Gu, Qingqing, Wang, Qingjie, Ji, Yuan, Sun, Ling
Formato:	research Journal Article
Publicado:	Springer Nature Apr2024
Acceso en línea:	Ver este registro en EBSCOhost